<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>PR.com Press Releases: Neal Mehta News</title>
		<link>https://www.PR.com/</link>
		<description>Latest news releases from PR.com for Neal Mehta.</description>
		<lastBuildDate>Tue, 12 May 2026 23:31:43 -0400</lastBuildDate>
		<copyright>&#169; 2026 PR.com</copyright>
		<ttl>60</ttl>
		<language>en-us</language>
		<image>
			<url>https://www.PR.com/images/logo_white.jpg</url>
			<title>PR.com Press Releases: Neal Mehta News</title>
			<link>https://www.PR.com/</link>
			<width>68</width>
			<height>69</height>
			<description>PR.com provides press release distribution, and is a unique directory of businesses, products and services. Find full company profiles.</description>
		</image>
		<atom:link href="https://www.pr.com/rss/press-releases-2/565346.xml" rel="self" type="application/rss+xml" />
		<item>
			<guid isPermaLink="true">https://www.pr.com/press-release/939969</guid>
			<title>Neal Mehta Conducts Research on Controlling Inflammation with Synthetic Peptides</title>
			<pubDate>Tue, 03 Jun 2025 07:25:20 -0400</pubDate>
			<description>Neal Mehta, a recent biology graduate from Pepperdine University, has made advances in biomedical research. Neal&#8217;s work focuses on the use of synthetic peptides to control inflammation, offering a new approach to treating chronic diseases.  Mehta, who graduated summa cum laude in May 2025, led research that explored how engineered peptides can modulate inflammatory signaling pathways. This approach offers a [PR.com]</description>
			<link>https://www.pr.com/press-release/939969</link>
			<dc:creator>Neal Mehta</dc:creator>
		</item>
	</channel>
</rss>